https://orcid.org/0000-0003-2320-0745
References
- Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111:1641–1648. doi:10.1016/j.ophtha.2004.03.029
- Sakata R, Aihara M, Murata H, et al. Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment. J Glaucoma. 2013;22(3):250–254. doi:10.1097/IJG.0b013e31823298fb
- Kim M, Kim DM, Park KH, et al. Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study. Acta Ophthalmol. 2013;91(4):e270–e275. doi:10.1111/aos.12082
- Komori S, Ishida K, Yamamoto T. Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up. Graefes Arch Clin Exp Ophthalmol. 2014;252(12):1963–1970. doi:10.1007/s00417-014-2767-3
- Erdem E, Williams A, Kuchar SD, Waisbourd M, Spaeth GL. Long-term (>8 years) evaluation of progression in patients with low-pressure glaucoma. Eur J Ophthalmol. 2015;25(6):490–495. doi:10.5301/ejo.5000624
- Tsumura T, Yoshikawa K, Kimura T, et al. The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients. Clin Ophthalmol. 2014;8:1681–1687. doi:10.2147/OPTH.S67366
- Mizoue S, Nitta K, Shirakashi M, et al. Multicenter, randomized, investigator-masked study comparing brimonidine tartrate 0.1% and timolol maleate 0.5% as adjunctive therapies to prostaglandin analogues in normal-tension glaucoma. Adv Ther. 2017;34(6):1438–1448. doi:10.1007/s12325-017-0552-5
- Yamamoto T, Iwase A, Araie M, et al. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005;112(10):1661–1669. doi:10.1016/j.ophtha.2005.05.012
- Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004;9(4):458–465. doi:10.1111/j.1440-1843.2004.00637.x
- Anderson DR, Patella VM. Automated Static Perimetry. 2nd ed. St Louis: Mosby; 1999:121–190.
- Lee JY, Sung KR, Lee JY. Comparison of the progression of high- and low-tension glaucoma as determined by two different criteria. Korean J Ophthalmol. 2016;30:40–47. doi:10.3341/kjo.2016.30.1.40
- Sakata R, Yoshitomi T, Iwase A, et al. Factors associated with progression of Japanese open-angle glaucoma with lower normal intraocular pressure. Ophthalmology. 2019;126:1107–1116. doi:10.1016/j.ophtha.2018.12.029
- Aoyama A, Ishida K, Sawada A, Yamamoto T. Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma. Jpn J Ophthalmol. 2010;54(2):117–123. doi:10.1007/s10384-009-0779-z
- Iverson SM, Schultz SK, Shi W, Feuer WJ, Greenfield DS. Effectiveness of single-digit IOP targets on decreasing global and localized visual field progression after filtration surgery in eyes with progressive normal-tension glaucoma. J Glaucoma. 2016;25(5):408–414. doi:10.1097/IJG.0000000000000240
- Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S; Low-Pressure Glaucoma Study Group. A randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment study. Am J Ophthalmol. 2011;151(4):671–681. doi:10.1016/j.ajo.2010.09.026
- Araie M, Adachi M. [Effect of topical 0.1% brimonidine tartrate and 0.5% timolol maleate on pulmonary and cardiovascular functions]. Nippon Ganka Gakkai Zasshi. 2012;116(7):623–634. [in Japanese].